诺普拉赞:对Helicobacter pylori感染的审查
1Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. demail@springer.com.
Drugs
|February 22, 2024
概括
诺普拉桑通过提供强大的酸抑制,提供了改进的Helicobacter pylori根除,与标准质子抑制剂 (PPI) 疗法不同. 这种新疗法显示出作为治疗H. pylori感染的有价值替代方案的希望.
科学领域:
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 杆菌感染是胃潰瘍疾病的主要原因,也是胃癌的危險因素.
- 目前基于质子抑制剂 (PPI) 的根除方案的成功率低于最佳,可能是由于酸抑制不足.
- 诺普拉桑是一种新型的竞争性酸阻塞剂,旨在强大且持续抑制酸性.
研究的目的:
- 评估基于vonoprazan的治疗方法在H. pylori根除方面的疗效和安全性.
- 为了比较基于vonoprazan的疗法与基于PPI的标准治疗方案.
- 建立vonoprazan作为一种有价值的替代H. pylori感染管理.
主要方法:
- 临床试验,包括美国和欧洲的PhALCON-HPIII期试验.
- 评估vonoprazan与阿莫西西林的双重治疗.
- 评估vonoprazan与阿莫西西林和澄胺三重治疗中的作用.
主要成果:
- 基于诺普拉桑的双重和三重治疗方案通常耐受良好.
- 诺普拉桑证明了强大而持续的酸性抑制的潜力.
- 经营营销售后经验支持的临床试验为诺普拉赞的批准和使用提供了依据.
结论:
- 基于诺普拉桑的疗法为基于PPI的标准三重疗法提供了一种有价值的替代方案,用于根除H. pylori.
- 诺普拉桑提供了诸如快速起作用和没有食物效应等优势.
- 诺普拉赞在美国的批准标志着H. pylori感染治疗的重大进展.
相关概念视频
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
403
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
403
01:26Peptic Ulcer Disease IV: Management
92
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
92
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
431
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
431
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
119
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
119
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
484
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
484
01:30Peptic Ulcer Disease I: Introduction
168
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
168